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During self-renewal of the hematopoietic stem cells there is a potential for these new cells to develop
into abnormal malignant cells due to environmental, chemical or microbial challenges. This may lead to
blood malignancies, including leukemia and lymphoma. Our laboratory was the ﬁrst to develop a
mouse model to study the development of lymphoma among pups of retrovirus infected mothers. We
have established that if the newborn pups suckle breast milk from the mothers infected with a
temperature sensitive Moloney Murine Leukemia Virus (MoMuLV-ts1), they develop lymphoma. Stem
and progenitor cell populations were determined from blood, spleen, and thymus samples in infected
mice with and without lymphoma using ﬂow cytometry and speciﬁc protein markers, including
CD117þ/CD34þ; CD117þ/Sca-1þ; CD135þ/Sca-1þ; Ter119þ/CD71þ and CD117þ/CD45þ . Some
stem cell populations were increased in infected mice with lymphoma. These stem cells appear to be
involved in the development of lymphoma in our mouse model.
& 2012 Elsevier Inc. All rights reserved.Introduction
During embryonic development, the pluripotential stem cells
by division and differentiation produce different organs. Each
organ contains stem cells which are capable of self-renewal.
These somatic organ speciﬁc stem cells are maintained for
differentiation and expansion as needed. The hematopoietic stem
cells (HSCs) are comprised of a group of complex cell populations
with the property of generation of multipotential and progenitor
cells which by further division and differentiation produce spe-
ciﬁc mature cell types in blood. Through multilineage differentia-
tion, they can grow into diverse groups of mature cells,
originating from pluripotential to progenitor cell lineages. Any
challenge including environmental, chemical, microbial or genetic
factors can cause mutations which can cause cellular abnormalities
leading to cancer. Therefore, carcinogenesis in the stem cells may be
caused by mutated stem cells producing ‘‘cancer stem cells’’ (Reya
et al., 2001; Pardal et al., 2005; Clarke and Fuller, 2006).
Cluster of differentiation (CD) and other antigens have been
used extensively as cell surface markers to determine the pheno-
type of normal and abnormal cells. For example, CD34þ and
CD38 phenotypes are present in groups of normal hematopoi-
etic stem cells (Bonnet and Dick, 1997; Hope et al., 2004), can alsoll rights reserved.
. Chakraborty).be seen in common leukemia stem cells (LSC) which produce
acute myeloid leukemia (AML). Therefore, multifunctionality,
including self-renewal, survival, proliferation and differentiation
are important steps for the origin of cancer stem cells which
under certain conditions develop into a malignancy.
By using appropriate antibodies and applying ﬂow cytometric
analysis, rapid identiﬁcation and quantitation of the cell subpo-
pulation can be achieved. Mouse cell surface antigens can be used
to determine the cell subpopulation and their role in the murine
disease process. Cancer stem cells (CSC) have been a subject of
great interest for many years. Most of the work on cellular origin
of cancer has been carried out using the in vitro cell culture
system. The correct microenvironmental condition of the conver-
sion of the normal cells to cancerous cells requires further
investigation using in vivo conditions. Although in vivo models
are time consuming and more difﬁcult to work with, these models
should be used for a better understanding of the stem cell origin
of cellular abnormality in cancer development.
We have developed a mouse model using a temperature
sensitive (ts1) mutant of the Moloney Murine Leukemia Virus
(MoMuLV) that can be effectively used for retrovirus-induced
immunosuppression in offspring of infected mothers. In this
model, mothers are initially infected by intraperitoneal injection
of ts1 within 10 day after birth. Nearly complete viral transmis-
sion (99%) is observed in pups allowed to suckle breast milk from
infected mothers (Chakraborty et al., 2003; Duggan et al., 2004).
The neonatal pups infected by this route of transmission later
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to paralysis of hind legs, loss of weight and lymphoma (Duggan
et al., 2004, 2006 and Chakraborty et al., 2008). Previously, we
have reported that CD4þ cell declines result in immunodeﬁ-
ciency (Duggan et al., 2006, 2012). We have demonstrated that
almost 100% of neonatal pups become infected and develop
clinical symptoms within a few months and almost 55% develop
lymphoma (Duggan et al., 2006; Chakraborty et al., 2008). The
animals which develop lymphoma die within 6 to 8 months
(Chakraborty et al., 2011; Duggan et al., 2012). If the control pups
suckle from infected surrogate mothers, then they develop
splenomegaly (95.7%), lymph node hypertrophy (79%) and thymic
hypertrophy (95.7%) (Duggan et al., 2012; Chakraborty et al.,
2011). Reduction of both CD4þ and CD8þ cells have also been
reported in these mice (Duggan et al., 2012). The objective of the
current investigation is to determine if this model can be used to
obtain further information on the involvement of stem cells in the
development of lymphoma in pups infected by breast milk from
infected mothers.Results
Gross appearances of the excised spleen and thymus from control
and experimental animals are shown in Fig. 1(A: control spleen,
B: experimental spleen; C: control thymus and D: experimental
thymus). Spleen and thymus of control animals were normal, while
those of experimental animals exhibited organomegaly. AverageFig. 1. (A) and (B) Spleen from control (A) and infected/lymphoma (B) mice illustratin
thymus and heart from control (C) and infected/lymphoma (D) mice at the same magnweight of control spleen was 0.11 g and the experimental spleen
was 0.76 g. The average weight of the control thymus was 0.03 g and
the experimental thymus was 0.10 g. We did not see any difference in
gross appearance of spleen and thymus of the infected/no lymphoma
group. The average weight of the spleen and thymus of the infected/
no lymphoma group were 0.16 g and 0.02 g, respectively. Histological
appearance of the spleen of the infected/lymphoma animals showed
many giant cells among densely packed splenocytes (Fig. 2).
Flow cytometry
Table 1 shows the antigen markers used for the ﬂow cytome-
try, with relevant information regarding each marker. As indi-
cated in Table 1, column 3, CD34þ , CD117þ , CD135þ and Ly-6A/
E (Sca-1þ) are hematopoietic stem and progenitor cell markers.
CD45þ , CD71þ , CD74þ and Ter119þ have been reported as
markers of cells at early developmental stages. The common
antigen can be present in different cell types (Table 1, column 3).
Fig. 3 represents the ﬂow cytometric ﬁgure of cell populations
with CD135/Sca1 marker of three representative animals from
control (A), infected/no lymphoma (B) and infected/lymphoma
(C) groups.
Blood samples showed a decrease in cell populations for
infected/no lymphoma with markers CD117þ/Sca-1þ (0.0%) com-
pared to control (0.01%), CD135þ/Sca-1þ (0.03%) compared to
control (0.14%), CD117þ/CD34þ (0.02%) compared to control
(0.03%), CD117þ/CD45þ (0.04%) compared to control (0.12%) and
Ter119þ/CD71þ (0.87%) compared to control (2.43%) (Table 2).g degree of splenomegaly at the same magniﬁcation. (C) and (D) Comparison of
iﬁcation, showing the degree of thymomegaly.
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CD135þ/Sca-1þ (0.06%) when compared to control(0.14%). In this
group, average cell population increased as follows: CD117þ/Sca-
1þ (0.08%) compared to control (0.01%), CD117þ/CD34þ (0.75%)
compared to control (0.03%), CD117þ/CD45þ (1.15%) compared to
control (0.12%) and Ter119þ/CD71þ (2.45%) compared to control
(2.43%). None of these were statistically signiﬁcant (Table 2). The
cell population exhibited a very high individual variability with a
wide range, for example CD117þ/CD34þ marker showed a range of
0.02 to 2.01 with an average of 0.75 and standard deviation 0.85.
Overall the cell subpopulation changes for selected markers are
illustrated in Fig. 4. In spleen samples, the variation among the cell
populations trended in the same direction for both infected/no
lymphoma and for infected/lymphoma groups. In infected/no lym-
phoma spleen samples, the average cell population increased as
follows: CD117þ/Sca-1þ (0.05%) compared to control (0.02%),
CD135þ/Sca-1þ (0.12%) compared to control (0.10%), CD117þ/
CD34þ (0.12%) compared to control (0.04%) CD117þ/CD45þ
(0.16%) compared to control (0.17%) and Ter119þ/CD71þ (6.20%)
compared to control (3.08%). For the infected/lymphoma group, theFig. 2. Histology of the spleen from a mouse with infected/lymphoma (severely
enlarged—weight of 1.623 g). Loss of general architecture. Presence of increased
numbers of small cells, giant cells are deep inside the spleen: 480.
Table 1
This table represents the cellular markers used for ﬂow cytometry with their relevant
Source: http://www.ebioscience: Mouse CD and non CD cellular antigens.
Antigen names
(Ref. no.)
Other names Distribution
CD34 (Craig et al., 2008;
Lai et al., 1998)
Mucosialin Hematopoietic precursor
endoth, BM stroma, mast
CD45 (Craig et al., 2008;
Lai et al., 1998)
LCA, Ly-5, Ptprc Leukocytes, not mature
erythrocytes. T subset, B,
NK progenitors
CD71 (Craig et al., 2008;
Lai et al., 1998)
T9, Trfr Proliferating cells, reticul
erythroid precursors
CD74 (Lai et al., 1998) Ii, Ia-invariant chain B, mac, mono
CD117
(Craig et al., 2008;
Francke et al., 2011;
Pulendran et al., 1997;
Zayas et al., 2008)
c-kit, steel factor Hematopoietic stem & pr
neural crest-derived mela
primordial germ cells, ma
CD 135 (Pulendran et al.,
1997)
Flt3/Flk2, EMS-like tyr
kinase 3
Hematopoietic progenito
& primitive B progenitors
Ly-6A/E (Lai et al., 1998;
Ma et al., 2002)
Sca-1 Hematopoietic progenito
subset, peripheral lymph
cells
Ter119 (Lai et al., 1998) Ly-76 Early proerythroblast to m
erythrocytetrend of increase in the cell population was similar, with CD117þ/
Sca-1þ (0.15%) compared to control (0.02%), CD135þ/Sca-1þ
(0.17%) compared to control (0.10%), CD117þ/CD34þ (1.56%)
compared to control (0.04%), CD117þ/CD45þ (5.35%) compared
to control (0.17%) and Ter119þ/CD71þ (5.20%) compared to
control (3.08%) (Table 3). The overall increase was consistently
higher in animals in the infected/lymphoma group (Fig. 5). None
of the increases were signiﬁcant. Thymus samples showed increases
of cell populations both in the infected/lymphoma and infected/no
lymphoma groups. In the thymus tissues of the infected/no lym-
phoma group, the average cell populations were as follows:
CD117þ/Sca-1þ (0.19%) compared to control (0.03%), CD135þ/
Sca-1þ (0.84%) compared to control (0.26%), CD117þ/CD34þ
(0.26%) compared to control (0.01%), CD117þ/CD45þ (0.40%)
compared to control (0.05%) and Ter119þ/CD71þ (0.31%) com-
pared to control (0.09%). Cells with CD135þ/Sca-1þ , CD117þ/
CD34þ and Ter119þ/CD71þ markers showed signiﬁcant increases
in infected/no lymphoma group. For the infected/lymphoma group,
average increases in the cell subpopulation were: CD117þ/Sca-1þ
(0.38%) compared to control (0.03%), CD135þ/Sca-1þ (0.44%)
compared to control (0.26%), CD117þ/CD34þ (1.86%) compared
to control (0.01%), CD117þ/CD45þ (5.27%) compared to control
(0.05%) and Ter119þ/CD71þ (0.24%) compared to control (0.09%)
(Table 4). It is noteworthy that the largest increases occurred with
cell markers CD117þ/CD34þ and CD117þ/CD45þ for the infected
lymphoma group. However, these increases were not statistically
signiﬁcant (Table 4). Fig. 6 shows the overall changes in cell
populations.Discussion
We have previously reported that if the pups of uninfected
BALB/c mice suckle from ts1 infected surrogate mothers after
birth almost 55% of them develop lymphoma (Duggan et al., 2006;
Chakraborty et al., 2008). We have also reported that infected
mice with lymphoma had a signiﬁcant reduction in CD4þ and
CD8þ cell counts in their blood and spleen samples, but were
without a signiﬁcant decline in these cells in the thymus (Duggan
et al., 2012). However, in infected animals with lymphoma, theinformation from different sources indicated in the parenthesis.
Gene symbol Chr. no. Function
s, capillary
cells
Cd34 1 CD62L receptor, adhesion
mono, mac.
Ptprc 1 Tyrosine phosphatase, leukocyte
differentiation/activation, pan-
leukocyte marker
ocytes, Trfr – Transferrin receptor, iron uptake,
cell activation
Ii 18 MHC class II trafﬁc & function,
antigen presentation
ogenitors,
nocytes,
st cells
c-kit 5 Stem cell factor receptor,
hematopoietic progenitor
development & differentiation,
dominant white spotting
(w) mutation
rs: myeloid Flt3 5 Binds FLT3 ligand, myeloid &
lymphoid development, expands
hematopoietic progenitors & DC
rs, myeloid
oid, mast
Ly6a 15 T activation
ature Ly76 – w/glycophorinA, but not a typical
glycophorin
Fig. 3. Flow cytometric analysis of three blood samples from each of control (A), infected/no lymphoma (B) and infected/lymphoma mice (C). The analyses were done in
fresh blood samples from a total of 16 animals: 4 controls, 6 animals infected/no lymphoma and 6 animals infected/lymphoma. An average of 7000 events were observed
per sample. The statistical analyses of data were performed using Student’s t-test with a signiﬁcant value set at p value r0.05.
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thymus (Duggan et al., 2012). During this investigation we have
used hematopoietic stem cell/progenitor cell markers to examine
if any of the observed stem/progenitor cell population increases
or decreases can be linked to the lymphoma development among
chronically infected pups, with the temperature sensitive mutant
ts1 of MoMuLV. However, due to extreme individual variability
between animals, it was not possible to draw a conclusion on
this issue.
Although previously we have identiﬁed the association of the
decrease or increase of mature differentiated cell populations in
animals with infected/lymphoma and infected/no lymphoma
(Duggan et al., 2012), further investigation was needed to under-
stand the cellular abnormalities of the hematopoietic stem/progenitor cell populations. Since cancer stem cells may play a
crucial role in the development of malignancy, the identiﬁcation
of these cell populations is very important for prognostic and
therapeutic applications. For example, CD117þ/CD34þ , a protein
marker present on the stem cell membrane (Table 1) was
increased in the blood, spleen and thymus of the infected/
lymphoma group of our animals, showing an abnormal stem cell
lineage in these tissues. However, the same marker was decreased
in the infected/no lymphoma group indicating the involvement of
this cell type delaying lymphoma development. Other stem/
progenitor cell markers including CD117þ/Sca-1þ were high in
the animals with infected/lymphoma in comparison to the
infected/no lymphoma group. These observations suggest that
some markers may be used to investigate stem/progenitor cell
Table 2
Blood.
Table 2 represents the cell populations of three different groups of animals, using ﬁve sets of cell surface markers for ﬂow cytometric analysis. This table shows the
average percent of cell subpopulation for each type of marker set. The range in percent of cell population for each experiment are also shown with standard deviation and p
values.
Cell marker Group—total sample (n) Average STD DEV Min Max po0.05
CD117þSca-1þ Control (6) 0.01 0.01 0.00 0.03 na
Infected no lymphoma (4) 0.00 0.00 0.00 0.00 0.06
Infected lymphoma (6) 0.08 0.15 0.00 0.39 0.34
CD135þSca-1þ Control (6) 0.14 0.12 0.04 0.35 na
Infected no lymphoma (4) 0.03 0.04 0.00 0.08 0.125
Infected lymphoma (6) 0.06 0.05 0.01 0.14 0.184
CD117þCD34þ Control (6) 0.03 0.04 0.00 0.10 na
Infected no lymphoma (4) 0.02 0.03 0.00 0.06 0.43
Infected lymphoma (6) 0.75 0.85 0.02 2.01 0.06
CD117þCD45þ Control (6) 0.12 0.15 0.01 0.42 na
Infected no lymphoma (4) 0.04 0.05 0.00 0.11 0.363
Infected lymphoma (6) 1.15 1.90 0.00 4.90 0.215
Ter-119þCD71þ Control (6) 2.43 1.04 1.23 3.83 na
Infected no lymphoma (4) 0.87 1.11 0.27 2.54 0.054
Infected lymphoma (6) 2.45 1.77 0.82 5.31 0.985
This table represents the average percentage of cell subpopulations from blood samples of control, infected/no lymphoma and infected/lymphoma mice using different
markers of mouse cell surface antigens.
Fig. 4. Bar chart of cell populations of markers of hematopoietic stem and progenitor cells from blood samples for control, infected/no lymphoma and infected/lymphoma
mice. Each bar represents animals with one set of markers. Statistical analyses were performed using Student’s t-test with a signiﬁcant value set at pr0.05.
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due to individual variability among animals, the standard devia-
tion of the cell populations were very high, for example, standard
deviation of the cell populations with marker CD117þ/CD34þ
were 0.85, 1.81 and 2.55 for blood, spleen and thymus, respec-
tively, (Tables 2–4) making it difﬁcult to draw any conclusion. In
our next experiment we plan to examine the tumor suppressors
and activators by using appropriate markers for ﬂow cytometry.
We will also extend our study to RT-qPCR using bone marrow
samples. To understand the stem cell involvement in cancer
development an extensive study of bone marrow cells needs to
be carried out. During the current investigation we only collected
blood, spleen and thymus tissues. Therefore, no bone marrow
cells were available to us. In the current investigation we have
noted the trend of the increase or decrease of cell populations in
animals that develop lymphoma. In our future studies we will use
bone marrow cells to answer some of the questions raised during
this investigation.
Hematopoietic stem cell development and differentiation play
a crucial role in lymphoma development. For example, the decline
in activation of the tumor suppressor gene can cause cellularproliferation leading to cancer, while an increase in its activation
may lead to cell death, thus accelerating the process of aging.
Proper development and function of T-cells are related to normal
cellular function of the immune system. Fan (1997) reported a
mixture of CD4/CD8; CD4þ/CD8; CD4þ/CD8þ; or CD4/
CD8þ in the T-cell lymphoma of MoMuLV infected mice. The
stem cells are long lived. They produce partially differentiated
progenitor or transit-amplifying cells. The progenitor cells pro-
duce terminally differentiated cells, as has been well studied in
male germline and hematopoietic stem cell lines, which produce
sperm and blood cells, respectively. Due to loss of normal growth
suppressor, the stem cells may progress to malignant cells. If the
stem cells are affected due to infection leading to T-cell damage
and resulting in weak immunity, this may lead to the decline in
apoptosis resulting in development of cancer (Grandics, 2006).
Therefore, it is important to understand the effects of an onco-
genic retrovirus such as ts1 virus in the development of lym-
phoma and understanding the effects of viral infection on stem
cells and stem cell marker proteins as an important step in this
process. In conclusion, the slow onset of lymphoma development
in our mouse model provides an opportunity to study the various
Table 3
Spleen.
Table 3 represents the cell populations of three different groups of animals, using ﬁve sets of cell surface markers for ﬂow cytometric analysis. This table shows the
average percent of cell subpopulation for each type of marker set. The range in percent of cell population for each experiment are also shown with standard deviation and p
values.
Cell marker Group—total sample (n) Average STD DEV Min Max po0.05
CD117þSca-1þ Control (6) 0.02 0.01 0.00 0.04 Na
Infected no lymphoma (4) 0.05 0.04 0.02 0.11 0.09
Infected lymphoma (6) 0.15 0.22 0.01 0.59 0.18
CD135þSca-1þ Control (6) 0.10 0.06 0.04 0.22 Na
Infected no lymphoma (4) 0.12 0.05 0.06 0.18 0.671
Infected lymphoma (6) 0.17 0.13 0.07 0.42 0.25
CD117þCD34þ Control (6) 0.04 0.03 0.00 0.07 Na
Infected no lymphoma (4) 0.12 0.10 0.04 0.26 0.08
Infected lymphoma (6) 1.56 1.81 0.05 4.69 0.07
CD117þCD45þ Control (6) 0.17 0.14 0.04 0.42 Na
Infected no lymphoma (4) 0.16 0.11 0.06 0.30 0.902
Infected lymphoma (6) 5.35 9.01 0.02 22.83 0.19
Ter-119þCD71þ Control (6) 3.08 1.69 1.68 6.43 Na
Infected no lymphoma (4) 6.20 2.24 3.57 8.35 0.036
Infected lymphoma (6) 5.20 4.73 0.53 12.35 0.33
This table represents the average percentage of cell subpopulations from spleen samples of control, infected/no lymphoma and infected/lymphoma mice using different
markers of mouse cell surface antigens.
Fig. 5. Bar chart of cell subpopulations of markers of hematopoietic stem and progenitor cells from spleen samples for control, infected/no lymphoma and infected/
lymphoma mice. Each bar represents animals with one set of markers. Statistical analyses were performed using Student’s t-test with a signiﬁcant value set at pr0.05.
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to progenitor to precursor to mature cell types under in vivo
conditions. Although we have extensively studied the spleen and
thymic cells, blood samples need to be studied in further detail in
the future since blood will be easier to collect and have the
potential to be used for diagnostic or therapeutic purpose in the
future. Further studies using stem/progenitor cell markers in this
mouse model will be highly valuable for basic understanding of
lymphoma development due to perinatal retroviral infection.Materials and methods
MoMuLV-ts-1 virus culture and assay
As previously described (Wong et al., 1973; Chakraborty et al.,
2003; Duggan et al., 2006) the MoMuLV-ts-1 was cultured in
thymus-bone marrow (TB) cells for viral culture and assayed in
15F cells. The cells and viral stock were provided by Dr. Paul K.Y.Wong at the University of Texas, M.D. Anderson Cancer Center,
Smithville, Texas. TB cells were grown in Dulbecco modiﬁed eagle
medium (DMEM) containing 6% fetal calf serum, 4% newborn calf
serum and 1% penicillin/streptomycin at 37 1C. At 70–80% con-
ﬂuency the TB cells were split and 1106 cells were seeded into
new ﬂasks with fresh media. For virus culture, TB cells were
grown in DMEM containing 3% newborn calf serum, 1% penicillin/
streptomycin and 1.5 mg polybrene overnight at 37 1C. The
following day, ts1 was added at the concentration of 1106
focus forming unit (ffu)/ml to the TB cells, and incubated at 34 1C
for 40 min. Then the cells were cultured using the same DMEM
medium as described above for an additional 3 day at 34 1C until
the cells reached 70–80% conﬂuency. Finally, the media contain-
ing the free retrovirus particles was ﬁltered through a 0.45 mm
ﬁlter and the viral suspension was aliquoted in 1 ml portions and
stored at 80 1C.
For viral assay 15F cells were cultured in the same medium as
described for TB cells. Then 9.6106 cells were plated in 60 mm
culture plates containing polybrene and grown overnight. Serial
Table 4
Thymus.
Table 4 represents the cell populations of three different groups of animals, using ﬁve sets of cell surface markers for ﬂow cytometric analysis. This table shows the
average percent of cell subpopulation for each type of marker set. The range in percent of cell population for each experiment are also shown with standard deviation and p
values.
Cell marker Group—total sample (n) Average STD DEV Min Max po0.05
CD117þSca-1þ Control (6) 0.03 0.05 0.00 0.12 Na
Infected no lymphoma (4) 0.19 0.26 0.03 0.58 0.18
Infected lymphoma (6) 0.38 0.68 0.02 1.76 0.24
CD135þSca-1þ Control (6) 0.26 0.31 0.10 0.89 Na
Infected no lymphoma (4) 0.84 0.27 0.46 1.09 0.02
Infected lymphoma (6) 0.44 0.80 0.04 2.06 0.61
CD117þCD34þ Control (6) 0.01 0.01 0.00 0.03 Na
Infected no lymphoma (4) 0.26 0.13 0.08 0.39 0.00
Infected lymphoma (6) 1.86 2.55 0.05 5.41 0.11
CD117þCD45þ Control (6) 0.05 0.06 0.00 0.16 Na
Infected no lymphoma (4) 0.40 0.66 0.03 1.38 0.21
Infected lymphoma (6) 5.27 7.20 0.05 19.04 0.11
Ter-119þCD71þ Control (6) 0.09 0.04 0.04 0.16 Na
Infected no lymphoma (4) 0.31 0.19 0.07 0.53 0.02
Infected lymphoma (6) 0.24 0.27 0.02 0.73 0.21
This table represents the average percentage of cell subpopulations from thymus samples of control, infected/no lymphoma and infected/lymphoma mice using different
markers of mouse cell surface antigens.
Fig. 6. Bar chart of cell subpopulations of markers of hematopoietic stem and progenitor cells from thymus samples for control, infected/no lymphoma and infected/
lymphoma mice. Each bar represents animals with one set of markers. Statistical analyses were performed using Student’s t-test with a signiﬁcant value set at pr0.05.
J.M. Duggan et al. / Virology 433 (2012) 377–384 383dilution of 10 viral stock were prepared and 0.5 ml of these
were added to the 60 mm plates containing the 15F cells in
duplicate, incubated at 34 1C for 40 min. After washing, the cells
were cultured in fresh DMEM for 2–3 day at 34 1C, media was
changed again and the cells were allowed to grow for an
additional 2–3 day until mature foci developed. The foci forming
units (ffu) were counted and viral concentration determined.
Mice
Twenty timed pregnant BALB/C mice were purchased from
Charles River Co. (Wilmington, ME). They were allowed to deliver
pups which were divided into experimental and control groups.
Seventy-two hours after delivery, pups from 12 mothers were
injected intraperitoneally with 0.2 ml of ts-1 virus at 4.0106 ffu/ml
concentration which served as the experimental group. The remain-
ing pups from eight mothers were intraperitoneally injected with
0.2 ml of DMEM only and served as the control group. On day 19, the
pups were weaned and all the males were discarded from both
groups leaving 18 female pups for the experimental and 15 female
pups for the control groups. These 33 female pups were allowed toreach maturity (6–8 weeks) and paired with males for mating.
After pregnancy, the females were isolated and allowed to deliver
pups. A total of 178 pups were produced by the 33 females. The
experimental mice produced 98 pups and the control mice produced
80 pups. The infected pups suckled from the infected surrogate
mothers and the control pups suckled from the control surrogate
mothers. All pups were allowed to suckle until the day of weaning
(19 day) and left to develop disease symptoms of lymphoma (6–8
months) (Duggan et al., 2012), indicated by hind leg paralysis,
kyphosis and abdominal distension. At this time, they were eutha-
nized and gross changes of the organs were noted and photographed.
Animals which did not develop lymphoma lived for a longer period
of time (14 to 20 months). They never developed lymphoma and
were euthanized when they reached the morbid condition indicated
by extremely lethargic condition with minimal movement and lack
of grooming activities as observed in healthy mice. Blood, spleen and
thymus tissues were collected for histology and ﬂow cytometry. The
same numbers of control animals were also euthanized and blood
and tissue samples were collected. The usual histological method of
making parafﬁn blocks and H&E staining were used for sample
preparation.
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For ﬂow cytometric study a Becton–Dickinson FACS caliburTM
(San Jose, CA) ﬂow cytometer was used following the ﬂow
cytometric technique previously described (Duggan et al., 2012).
Flow cytometric analyses of all fresh blood and tissue samples
were shipped in dry ice to Richard West at the Flow Cytometry
Core facility of Van Andel Research Institute, Grand Rapids,
Michigan. The following mouse antibodies were used as cellular
markers: CD117þ/Sca1þ; CD135þ/Sca1þ; CD117þ/CD34þ;
CD117þ/CD45þ; Ter119þ/CD71þ . Appropriate controls were
used for each run. Data were collected and student t-test was
applied for statistical analysis with pr0.05 set as statistically
signiﬁcant value.Acknowledgment
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